Stocks
Hepion Pharmaceuticals, Inc.HEPA
NASDAQHealthcareBiotechnology$0.06+3.33%
A clinical-stage biopharmaceutical company focused on developing treatments for chronic liver diseases, particularly nonalcoholic steatohepatitis (NASH). Its lead drug candidate, rencofilstat, is a cyclophilin inhibitor designed to target inflammation, fibrosis, and viral replication pathways. Inves...
Market Cap: $720,46052W Range: $0.03 – $1.15
Congressional Interest in Hepion Pharmaceuticals, Inc. (HEPA)
No congressional trades have been disclosed for Hepion Pharmaceuticals, Inc. (HEPA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading HEPA?
No congressional trades found for this stock.